Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$161,696,089
-$63,925,901 QoQ
Shares Held
1,717,978
-24.8% QoQ
Ownership
0.860%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 75.06021613780852.ToString("F0")%
Shared 0.ToString("F0")%
None 24.939783862191483.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $705,898,155 across 85 Biotechnology names. INCY ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
214,160 | $165,468,582 | |
| 2 | INCY |
Incyte Corp
This page
|
1,717,978 | $161,696,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
212,204 | $70,211,937 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
789,429 | $51,020,796 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,431,071 | $29,980,937 | |
| 6 | EXEL |
Exelixis, Inc.
|
425,982 | $18,270,367 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,097,189 | $16,260,340 | |
| 8 | ARVN |
Arvinas, Inc.
|
1,441,521 | $15,280,122 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $161,696,089 | 1,717,978 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $225,621,990 | 2,284,317 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $147,891,169 | 1,743,794 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $88,181,532 | 1,294,883 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $84,657,558 | 1,398,143 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $61,586,887 | 891,659 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,132,890 | 92,782 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,426,106 | 155,495 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $143,258,698 | 2,514,634 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $146,726,541 | 2,336,782 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $120,477,313 | 2,085,465 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $110,290,441 | 1,771,734 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $120,562,114 | 1,668,218 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $106,818,130 | 1,329,907 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $77,054,832 | 1,156,285 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $86,114,426 | 1,133,532 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $91,561,014 | 1,152,871 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $79,029,119 | 1,076,691 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $77,422,550 | 1,125,655 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $85,329,946 | 1,014,263 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $64,053,194 | 788,153 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $56,775,151 | 652,738 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $51,804,120 | 577,269 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $39,893,081 | 383,698 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $55,566,777 | 758,798 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||